Temsirolimus
Temsirolimus , sold under the brand name Torisel , is an intravenous drug for the treatment of renal cell carcinoma ( RCC ) , developed by Wyeth Pharmaceuticals and approved by the U . S . 
<triplet> Temsirolimus <subj> renal cell carcinoma <obj> medical condition treated <triplet> renal cell carcinoma <subj> Temsirolimus <obj> drug used for treatment